Godavari Drugs share news and announcements
BSE: 530317Pharmaceuticals & BiotechnologySmall Cap
Last close ₹120.50down ₹3.65 (2.94%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹124.15.
52-week range of traded prices to 23 Oct 2026
₹69.70Low, 9 Dec 2025₹144.35High, 12 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹122 Cr3,042nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 29.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 1.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,422
Godavari Drugs routine notices
104 filed, newest first. Page 3 of 3.
Aug 2016
May 2016
17 May · Routine
Meeting of the Board of Directors of the Company will be held on May 28, 2016, inter alia, to consider and approve the audited financial results ....
Jan 2016
30 Jan · Routine
Meeting of the Board of Directors of our Company will be held on February 09, 2016, to consider and approve the unaudited financial results ....
Oct 2015
28 Oct · Routine
Meeting of the Board of Directors of our Company will be held on November 06, 2015, to consider and approve the unaudited financial results ....